Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
about
Prevalence of diabetes mellitus in patients with acromegaly.The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.Elevated circulating somatostatin levels in acromegaly.
P2860
Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
@en
Increased glucose-dependent insulinotropic polypeptide
@nl
type
label
Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
@en
Increased glucose-dependent insulinotropic polypeptide
@nl
prefLabel
Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
@en
Increased glucose-dependent insulinotropic polypeptide
@nl
P2093
P356
P1476
Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly
@en
P2093
C Pagliari
M Peracchi
P Epaminonda
S Porretti
P356
10.1530/EJE.0.145R001
P577
2001-07-01T00:00:00Z